Zydus Life, Dr Reddy's partner to co-market Pertuzumab biosimilar for breast cancer treatment - CNBC TV18
Generic drugmaker Zydus Lifesciences Ltd on Friday (June 28) said it has entered into a licensing agreement with Dr Reddy’s Laboratories to co-market the Pertuzumab biosimilar, a critical treatment ...
CNBC TV18
3 days ago